Company intelligence / Profile preview

RenalGuard

Milford, Massachusetts, USA

Ownership: Private
Employees: ~30
Development stage: Other

Overview

RenalGuard Solutions is a medical technology company dedicated to preventing acute kidney injury (AKI) in high-risk patients. The company's flagship product, the RenalGuard System, is an automated fluid management device that facilitates high-volume forced diuresis while maintaining precise fluid balance. This approach is clinically proven to reduce the incidence of Contrast-Induced Nephropathy (CIN) during catheterization procedures and is being investigated for Cardiac Surgery-Associated AKI. Headquartered in Milford, Massachusetts, the company provides solutions that aim to improve clinical outcomes and reduce the costs associated with hospital-acquired kidney damage.

Therapeutic areas: Nephrology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on RenalGuard.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RenalGuard.

Explore the full profile